![Radiology technician examens mammography test on location](https://pharmaphorum.com/wp-content/uploads/2016/10/iStock_16019343_LARGE.jpg)
After setbacks for Roche and Sanofi, AZ scores oral SERD win
AstraZeneca seems to have dodged the problems besetting other developers of oral selective oestrogen receptor degrader (SERD) drugs with a phase 2 win for its candidate camizestrant in a ph